6533b7d0fe1ef96bd125a338
RESEARCH PRODUCT
Brugada syndrome induced by BRAF and MEK inhibitors in a melanoma patient.
Marc BadozBlandine Roche-kublerNicolas MeneveauEve PuzenatMorgane ColasCharlée NardinF. Aubinsubject
OncologyMaleProto-Oncogene Proteins B-rafmedicine.medical_specialtySkin NeoplasmsPyridonesMEDLINEPyrimidinones030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsOximesMedicineHumans030212 general & internal medicineMelanomaProtein Kinase InhibitorsBrugada syndromeBrugada SyndromeMelanoma patientbusiness.industryImidazolesMiddle Agedmedicine.diseaseCancer researchCardiology and Cardiovascular Medicinebusinessyear | journal | country | edition | language |
---|---|---|---|---|
2017-03-23 | European heart journal |